Lilly Partners With Marcadia For Injectable Pens To Treat Hypoglycemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Already a leader in emergency kits, Lilly will support trials on a simpler device that doesn't require complex preparation.
You may also be interested in...
Boehringer Enhances Diabetes Pipeline With Zealand's GLP-1/Glucagon Agonist
Boehringer wins global rights to Zealand's Phase I-ready novel diabetes compound, pledging €20 million during 2011.
Boehringer Enhances Diabetes Pipeline With Zealand's GLP-1/Glucagon Agonist
Boehringer wins global rights to Zealand's Phase I-ready novel diabetes compound, pledging €20 million during 2011.
Roche Acquires Diabetes Biotech Marcadia
In the wake of its taspoglutide disappointment, Roche is acquiring privately-owned U.S. metabolic treatment maker Marcadia Biotech for an undisclosed sum.